Tom Rossenbacker

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study

Jonathan P. Piccini, Valeria Caso, Stuart J. Connolly et al. · The Lancet · 2022 · 311 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +11

Abrupt rate accelerations or premature beats cause life-threatening arrhythmias in mice with long-QT3 syndrome

Dieter Nuyens, Milan Štengl, S. Dugarmaa et al. · Nature Medicine · 2001 · 252 citations

Medicine, Cardiology, Physiology +8

High yield of LMNA mutations in patients with dilated cardiomyopathy and/or conduction disease referred to cardiogenetics outpatient clinics

J. Peter van Tintelen, Robert M.W. Hofstra, Hilga Katerberg et al. · American Heart Journal · 2007 · 165 citations

Medicine, Cardiology, Genetics +8

Unifocal Right-Sided Ablation Treatment for Neurally Mediated Syncope and Functional Sinus Node Dysfunction Under Computed Tomographic Guidance

Philippe Debruyne, Tom Rossenbacker, Christine Collienne et al. · Circulation Arrhythmia and Electrophysiology · 2018 · 111 citations · Full text

Medicine, Cardiology, Cardiothoracic Surgery +9

Novel pore mutation in SCN5A manifests as a spectrum of phenotypes ranging from atrial flutter, conduction disease, and Brugada syndrome to sudden cardiac death

Tom Rossenbacker, Sheila J. Carroll, Huajun Liu et al. · Heart Rhythm · 2004 · 78 citations

Medicine, Cardiology, Genetics +17